Sign in

CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
850642577
Phone
650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. SCHEDULE 13D/A Stake Beneficial Ownership Report
  2. 8-K Event Material agreement · Unregistered share sale
  3. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 2,230 shares at $1.93 ($4,304)
  4. 4 Open-market sale SVP, FINANCE AND CAO sold 573 shares at $1.93 ($1,106)
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. 4 Open-market sale SVP, FINANCE AND CAO sold 1,404 shares at $2.04 ($2,864)
  10. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  11. 8-K Event Material agreement · Agreement ended · New debt or obligation
  12. 8-K Event Shareholder vote results
  13. SCHEDULE 13D/A Stake Beneficial Ownership Report
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. ARS Other Annual Report to Security Holders
  20. DEF 14A Proxy Proxy Statement

Page 1 of 22 · 421 filings